We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Defective Cell Extrusion May Lead to Formation of Tumors in Pancreas, Lungs, or Colon

By LabMedica International staff writers
Posted on 09 Feb 2015
Print article
The disruption of normal S1P2 (sphingosine-1-phosphate receptor 2) receptor activity in epithelial cells prevents the pro-apoptotic extrusion of cells from overcrowded tissue and leads to the formation of cancerous growths in the pancreas, lung, and colon.

When epithelial tissues become too crowded, some cells are extruded that later die. To extrude, a cell produces the lipid, sphingosine 1-phosphate (S1P), which activates S1P2 receptors in neighboring cells that seamlessly squeeze the cell out of the epithelium. Tumors or epithelia lacking S1P2 cannot extrude cells in the normal fashion, which can contribute to carcinogenesis and tumor progression.

Investigators at the University of Utah (Salt Lake City, USA) studied the extrusion process in a zebrafish model system. They reported in the January 26, 2015, online edition of the journal eLife that when S1P2 signaling was disrupted, cells built up and formed masses that resisted apoptosis—even when it was triggered by chemotherapy—or they slipped into underlying tissues where they could potentially begin to grow. Furthermore, some cells died without being extruded, creating poor barrier function in the epithelium, which could cause chronic inflammation.

Inducing S1P2 expression was found to be sufficient to restore extrusion and cell death and reduced pancreatic tumors and their metastases. An inhibitor of the enzyme FAK (focal adhesion kinase) was found to enable cells to bypass extrusion defects and could, therefore, target pancreatic, lung, and colon tumors that lacked S1P2 without affecting normal tissues.

"This kind of altered extrusion may be a common hallmark of invasive tumor types," said senior author Dr. Jody Rosenblatt, associate professor of oncological sciences at the University of Utah. "While the mechanisms that drive tumor cell invasion are not yet clear, the results suggest that S1P2-mediated extrusion may play an important role in metastatic cell invasion. Some FAK inhibitors are already being tested in clinical trials for other types of cancers. Hopefully, they may also be a better therapy for recalcitrant tumors such as pancreas cancers and some lung cancers."

Related Links:

University of Utah


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.